This document summarizes the key aspects of sterile manufacture of parenteral products. It describes the types of parenteral preparations, facility requirements including layout and laminar air flow, additives used in formulations, production planning such as cleaning, filling, and sealing processes. It also discusses the quality control tests including sterility, pyrogen, clarity, and leakage tests to ensure the sterile products are free of microorganisms and safe for patient use.
Capsules are solid dosage forms in which the drug or a mixture of drugs with or without excipients is enclosed in Hard Gelatin Capsule Shells, in soft, soluble shells of gelatin, or in hard or soft shells of any other suitable material, of various shapes and capacities. They usually contain a single dose of active ingredient(s) and are intended for oral administration.
Advantages:
The drugs having unpleasant odour and taste can be administered by enclosing them in a tasteless shell.
They are smooth, become very slippery when moist and can be easily swallowed.
They are economical.
They are easy to handle and carry.
The capsules release the medicament as and when desired in gastro-intestinal tract.
Capsules are made from gelatin and hence they are therapeutically inert.
Capsule have elegant appearance so that it enhance patient acceptance.
The drug in the form of solid, liquid & viscous form can be encapsulated in capsule shell.
Capsule formulation provide better stability of drug as compare to uncoated tablet & liquid dosage form.
Disadvantages:
Capsule are not usually used for administration of extremely soluble materials such as potassium chloride, potassium bromide etc. since there is sudden release of such compound in stomach & causes irritation.
Capsule should not used for highly efflorescent material as material may cause the capsule to soften by losing water molecule to shell.
Capsule should not used for highly deliquescent powder as powder have tendency to absorb moisture from capsule shell & make it brittleness.
The capsule shells can absorb water from the environment and develop problems with drug stability and capsule shell can become tacky.
It is unsuitable for use with liquid formulations.
The mechanism involved for production of hard gelatin capsule shell are
The Capsule shell contains :
Dry Gelatin (Type A or B)
Plasticizer – Glycerine
Solvent – Demineralised water
Preparation of the gelatin solution (dipping solution): A concentrated solution of gelatin (35- 40%) is prepared by dissolving the gelatin in demineralized water which has been heated to 60– 70°C in jacketed pressure vessels. This is stirred until the gelatin has dissolved and vacuum is applied to removed entrapped air bubbles. At this stage, other processing aids may be added like plasticizer, colourant, opaquing agent etc. The viscosity of gelatin preparation has to be controlled as it may affect downstream manufacturing process & very importantly thickness of shell. cap Body.
Dipping
Spinning
Drying
Stripping & Trimming
Joining
The mechanism involved for production of hard gelatin capsule shell are
The Capsule shell contains :
Dry Gelatin (Type A or B)
Plasticizer – Glycerine
Solvent – Demineralised water
Preparation of the gelatin solution (dipping solution): A concentrated solution of gelatin (35- 40%) is prepared by dissolving the gelatin in demineralized water which has been heated to 60– 70°C.
Capsules are solid dosage forms in which the drug or a mixture of drugs with or without excipients is enclosed in Hard Gelatin Capsule Shells, in soft, soluble shells of gelatin, or in hard or soft shells of any other suitable material, of various shapes and capacities. They usually contain a single dose of active ingredient(s) and are intended for oral administration.
Advantages:
The drugs having unpleasant odour and taste can be administered by enclosing them in a tasteless shell.
They are smooth, become very slippery when moist and can be easily swallowed.
They are economical.
They are easy to handle and carry.
The capsules release the medicament as and when desired in gastro-intestinal tract.
Capsules are made from gelatin and hence they are therapeutically inert.
Capsule have elegant appearance so that it enhance patient acceptance.
The drug in the form of solid, liquid & viscous form can be encapsulated in capsule shell.
Capsule formulation provide better stability of drug as compare to uncoated tablet & liquid dosage form.
Disadvantages:
Capsule are not usually used for administration of extremely soluble materials such as potassium chloride, potassium bromide etc. since there is sudden release of such compound in stomach & causes irritation.
Capsule should not used for highly efflorescent material as material may cause the capsule to soften by losing water molecule to shell.
Capsule should not used for highly deliquescent powder as powder have tendency to absorb moisture from capsule shell & make it brittleness.
The capsule shells can absorb water from the environment and develop problems with drug stability and capsule shell can become tacky.
It is unsuitable for use with liquid formulations.
The mechanism involved for production of hard gelatin capsule shell are
The Capsule shell contains :
Dry Gelatin (Type A or B)
Plasticizer – Glycerine
Solvent – Demineralised water
Preparation of the gelatin solution (dipping solution): A concentrated solution of gelatin (35- 40%) is prepared by dissolving the gelatin in demineralized water which has been heated to 60– 70°C in jacketed pressure vessels. This is stirred until the gelatin has dissolved and vacuum is applied to removed entrapped air bubbles. At this stage, other processing aids may be added like plasticizer, colourant, opaquing agent etc. The viscosity of gelatin preparation has to be controlled as it may affect downstream manufacturing process & very importantly thickness of shell. cap Body.
Dipping
Spinning
Drying
Stripping & Trimming
Joining
The mechanism involved for production of hard gelatin capsule shell are
The Capsule shell contains :
Dry Gelatin (Type A or B)
Plasticizer – Glycerine
Solvent – Demineralised water
Preparation of the gelatin solution (dipping solution): A concentrated solution of gelatin (35- 40%) is prepared by dissolving the gelatin in demineralized water which has been heated to 60– 70°C.
Pharmaceutical Aerosols: Definition, propellants, containers, valves, types of aerosol systems; formulation and manufacture of aerosols; Evaluation of aerosols; Quality control and stability studies
Pharmaceutical Solutions. Definition: Homogeneous liquid preparations that contain one or more chemical substances dissolved, i.e., molecularly dispersed, in a suitable solvent or mixture of mutually miscible solvents.
This pdf contain notes on STERILE DOSAGE FORM (PARENTRA), This notes is specilly used for D. pharm, B. Pharm & M. Pharm Students and respected faculties
Pharmaceutical Aerosols: Definition, propellants, containers, valves, types of aerosol systems; formulation and manufacture of aerosols; Evaluation of aerosols; Quality control and stability studies
Pharmaceutical Solutions. Definition: Homogeneous liquid preparations that contain one or more chemical substances dissolved, i.e., molecularly dispersed, in a suitable solvent or mixture of mutually miscible solvents.
This pdf contain notes on STERILE DOSAGE FORM (PARENTRA), This notes is specilly used for D. pharm, B. Pharm & M. Pharm Students and respected faculties
In Process Quality Control Tests (IPQC) For Parenteral or Sterile Dosage FormsSagar Savale
These are the tests performed between QA and QC and provides for the authorization of approved raw materials for manufacturing based on actual laboratory testing generally called as IPQC such as physical, chemical, microbiologic and biologic tests.
Parenterals are the sterile preparation that is directly administered into the circulatory system avoiding the enteral route. And these preparation provide rapid onset of action that is why the administered preparation must be safe.
Stability problem arise from microbial contamination of these products so sterility and stability must be ensured for these preparations.
To ensure their sterility and stability, regulations regarding to quality control through pharmacopeial specifications has great importance.
Sterility testing products (solids, liquids, ophthalmic and other sterile pro...Ms. Pooja Bhandare
PHARMACEUTICAL MICROBIOLOGY (BP303T)Unit-IIIPart-6 Sterility testing products (solids, liquids, ophthalmic and other sterile products) according to IP, BP, USP.
Introduction: Test for Sterility. Culture Media. Fluid Thioglycollate Medium (FTM).
Alternative Thioglycollate Medium (ATM).
Soybean Casein Digest Medium (SCDM).
Tests for Culture Media:
Sterility of Media.
Growth Promotion Test.
Test for Bacteriostatic and Fungistatic.
Sterility Test Methods. Methods A: Membrane Filtration.
Method B: Direct Inoculation Pyrogen Test Methods. Rabbit Test. LAL Test.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
2. Content
Types of parenteral:
Facilities requirement
Layout of sterile product area:
Additives used in parenteral or formulation of parenteral
Production planning and processing:
Tests for quality control:
3. Sterile products
Sterile product are dosage form which are free from viable micro-organism.
It includes parenteral and ophthalmic preparation and irrigating fluids.
Parenteral
Parenteral are liquid preparation which is sterile, non-pyrogenic and isotonic with blood
plasma and administered directly into blood plasma rather than taken by oral route.
4. Types of parenteral
PARENTERAL
Small volume parenteral: Large volume parenteral:
less than 50 or 100 ml quantity. more than 500 ml.(commonly available 250 ml, 500 ml and
1000 ml.)
Ex: ampoules, syringes, vial needles. Ex; glass, plastic container
5. Facility requirement
Environmental control
Traffic control
Housekeeping
Surface disinfection
Air control
Laminar air flow
1. Horizontal air flow- use for filling of parental.
2. Vertical air flow-use for sterility testing procedure.
6. Laminar air flow
Definition:
• It provides unidirectional flow of air, which sweeps away dust, dirt, fibers, and microorganism &
• gives clean air moving with uniform velocity along with parallel line.
• It contains HEPA filters- Which filter air & remove particles up to 0.3 micron with an efficiency of 99.97%.
• It is used to carry out sterility testing, filling process & microbiological testing like bio-assay.
HEPA Filter:
• HEPA is the 'High Efficiency Particulate Air Filter, the air in the aseptic area should be free from
• fibers, dust and microbes. This can be achieved by the use of HEPA filter.
• The HEPA filters are used in the 'laminar air flow in which the air flows either horizontally or
• vertically along parallel lines.
7. Layout of sterile product area:
The sterile area can be divided into following categories:
1) Clean up area
2) Compounding or preparation area
3) Aseptic area
4) Quarantine area
5) Packaging & labeling area
8. Additives used in parenteral or Formulation of Parenteral
1. Vehicles
2. Anti-microbial agent
3. Antioxidant
4. Buffer
5. Preservatives
6. Tonicity contributors
9. .
Additives Description Example
Vehicle There are two types of vehicles are
Aqueous vehicle
Non-aqueous vehicle
Aqueous V- WFI, Sterile WFI
Non aqueous V-oil and alcohol
Anti microbial agent To prevent microbial growth Cresol, chlorocresol, benzyl alcohol
Anti-oxidant To prevent oxidative degradation of
parenteral products
Ascorbic acid, thiourea, acetone,
BHA,BHT, tocopherol
buffers Used to resist change in pH
or to maintain pH
Citrate, phosphate & acetate of sodium,
potassium
Preservative These agents preserve the drugs and
make product stable.
Benzalconium chloride -0.001%
Chlorobutanol--0.5%,
Tonicity adjustifire Some injection need to be isotonic with
the blood or other body fluid
Dextrose, sodium chloride.
Suspenind,
emulsifying, wetting
agent
To maintain particle size and prevent
flocculation and caking
Wetting agent: tween 80, sorbiton trioleate
Suspending agent: PVP, methyl cellulose,
acacia
Emulsifying agent: lecithin
10. Production planning and processing:
1. Cleaning the equipment
2. Cleaning the containers and closure
3. Preparation of solution and suspension
4. Filling of product in ampoules/vials
5. Sealing
6. Sterilization
7. Test for quality control
11. .
Production planning and processing Description
Cleaning the equipment Dichromate solution is used for glassware rubber tubing followed by rinsing with
distilled water.
Cleaning the containers and closure Closures are agited vigorously in hot solution of 0.5% sodium pyrophosphate
rinsed several times with water and finally distilled water.
Preparation of solution and suspension Solution prepared under aseptic condition.
filtration Seitz filter, sintered glass filter and membrane filter.
Filing of product in ampoules/vials The filtered product is fill in the ampoules with the help of semi-automatic
automatic machine under aseptic condition.
Sealing Sealing should be done immediately after filling under aseptic condition only.
Sealing of ampoules is done by two methods.
i) Tip sealing ii) Pull sealing
Sterilization Sterilization is done by various methods depends upon nature of preparation.
Drugs sterilization is carried out either autoclave at temperature 121° C for 15 to
20 minute.
12. Filling of product:
During filling product contamination is avoided as product is exposed to environment and equipment, hence it
should be done under aseptic area.
Two types of units are used
1. Blow fill seal (BFS)
2. Form fill seal( FFS)
this both technique are used to manufacture sterile pharmaceutical products.it is used to reduce contamination by
forming container and, filling and sealing the container.
Form fill seal ( FFS) Blow Fill seal( BFS)
FFS are automated machine, in which through one
continuous operation container are formed from
thermoplastic granules
BFS are machines in which container are molded(
Preformed) by non continuous operation
13. Sealing
Sealing of filled container should be done immediately to prevent product contamination
The ampoules are sealed by melting portion of glass neck with jet of flame ( oxygen flame) this is done by
2 methods:
Tip seal (bead seal) and pull seal
The vials and bottles are sealed by rubber closure (stopper)
Tip seal Pull seal
Tip of ampoule neck is heated to form bead which
closes the opening
Littlie below tip ampoule is heated
The tip is grasped firmly and pulled quickly with
rotation of ampoule neck
It is fast but not sure, excessive heating may cause
bubble on tip
It is slow but more sure.
15. Equipment for parenteral
Storage equipment for ampoules, vials, bottles, closures,
washing and drying equipment,
water stills, storage for distilled water,
mixing equipment,
hot air oven, autoclave, cold storage & refrigeration unit,
sintered glass funnel, filter press, filtering equipment,
equipment for evaluation and quality control, labelling and packaging
filling and sealing unit
laminar air flow bench with HEPA filters, ultraviolet ray tubes, air blowers with fresh air.
16. Test for QC or evaluation of parenteral
Sterility test
Pyrogen test
Clarity test
Leakage test
17. Pyrogen test :
Pyorgens are metabolic waste product of microorganism mostly gram negative bacteria
Chemically pyrogens are lipopolysaccharide and this are fever producing agent.
Pyrogen testing is defined as process used by drug manufacturer to determine if bacterial toxins are
present in drug which causes increase in fever.
Fever response to pyrogen in rabbit is basis for official pyrogen test
New Zealand or Belgian white rabbit breads are used for testing.
Following are pyrogen test:
1.a) SHAM test – (preliminary test)
b) Rabbit test- (main test ) both are old method and in vivo test
2. LAL test- ( Limulus Amebocyte Lysate test)- new method and invitro test
For procedure and limit of sham and rabbit test refer experiment no.3.
18. LAL test- ( Limulus Amebocyte Lysate test)-
Another test for detection of pyrogen the sample solution to be tested is combined with lysate of blood
cells ( amebocytes ) of horseshoe crab.
If pryogens are present in the sample then blood are coagulated with protein of the blood cells and result in
the formation of gel.
19. Sterility test:
• The product should be free from living microorganism and their spores.
Principle:
• Sample tested is transferred into test tube containing sterile culture media under ascetic
condition for growth of aerobic and anaerobic microorganism.
• The growth can be detected easily because the clear medium turns turbid.
Following media are used:
a) Fluid Thio-glycollate medium (For detection of aerobic and anaerobic bacteria)
b) Soybean casein digest medium (For detection of fungi and aerobic bacteria)the sample.
• The sample introduced in the culture medium should be kept in incubators at 30°C for 7days.
• If there is no visible growth. The sample passes sterility test .
• if turbity is seen i.e. culture medium is not clear sample cannot passes sterility test.
Procedure for sterility test
1. Membrane filtration
2. Direct inoculation
20. Continue…
Leaker test:
Principal: An ampoule is sealed by fusion method. It is done to see sealing is proper or not.
It is performed in a vacuum chamber. The ampoule is dipped entirely in colored dye solution. A
1%Methylene blue solution is usually used .After releasing the vacuum ampoule is checked to see if dye
has entered the parenteral preparation.
Clarity Test:
Principal: the parenteral sample is injected for particular matter like dust particle.
Any ampoule bottle or vial can be seen under light against black and white background by the naked
eyes. To perform this test the neck of filled container can be held against strongly illuminated screen. If
some particles are visible the sample is rejected.